Pharmacokinetics and pharmacodynamics of antibiotics in meningitis.

[1]  J. Sippel,et al.  Rifampin concentrations in cerebrospinal fluid of patients with tuberculous meningitis. , 2015, The American review of respiratory disease.

[2]  G. Mccracken,et al.  Antibiotic pharmacodynamics in cerebrospinal fluid. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Pfaller,et al.  Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  H. Jafri,et al.  Pharmacodynamics of Gatifloxacin in Cerebrospinal Fluid in Experimental Cephalosporin-Resistant Pneumococcal Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[5]  F. Sörgel,et al.  Disposition and Elimination of Meropenem in Cerebrospinal Fluid of Hydrocephalic Patients with External Ventriculostomy , 1998, Antimicrobial Agents and Chemotherapy.

[6]  M. Jacobs,et al.  Postantibiotic Effect of Trovafloxacin against Gram-Positive and -Negative Organisms , 1998, Antimicrobial Agents and Chemotherapy.

[7]  K. Olsen,et al.  Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis , 1997, Antimicrobial agents and chemotherapy.

[8]  C. Berkey,et al.  Dexamethasone as Adjunctive Therapy in Bacterial Meningitis. A Meta-Analysis of Randomized Clinical Trials Since 1988 , 1997 .

[9]  J. Barré,et al.  Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin , 1997, Antimicrobial agents and chemotherapy.

[10]  Lisa Licata,et al.  Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.

[11]  F. Sörgel,et al.  Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients , 1997, Antimicrobial agents and chemotherapy.

[12]  M. Täuber,et al.  Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae , 1997, Antimicrobial agents and chemotherapy.

[13]  G. Mccracken,et al.  Once-daily gentamicin therapy for experimental Escherichia coli meningitis , 1997, Antimicrobial agents and chemotherapy.

[14]  J. Hindler,et al.  Comparative activity of twelve beta-lactam drugs tested against penicillin-resistant Streptococcus pneumoniae from five medical centers: effects of serum protein and capsular material on potency and spectrum as measured by reference tests. , 1996, Diagnostic microbiology and infectious disease.

[15]  G. Doern,et al.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study , 1996, Antimicrobial agents and chemotherapy.

[16]  M. Kinzig,et al.  Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies , 1996, Antimicrobial agents and chemotherapy.

[17]  G. Mccracken,et al.  Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae , 1996, Antimicrobial agents and chemotherapy.

[18]  J. Bradley,et al.  Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis , 1995, Antimicrobial agents and chemotherapy.

[19]  C. Cabellos,et al.  Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis , 1995, Antimicrobial agents and chemotherapy.

[20]  G. Mccracken,et al.  Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1995, Antimicrobial agents and chemotherapy.

[21]  G. Mccracken,et al.  Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children , 1995, Antimicrobial agents and chemotherapy.

[22]  J. Froula,et al.  Quinolone antibiotics in therapy of experimental pneumococcal meningitis in rabbits , 1995, Antimicrobial agents and chemotherapy.

[23]  R. Dagan,et al.  Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges. , 1994, The Journal of antimicrobial chemotherapy.

[24]  K. Olsen,et al.  Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1994, Antimicrobial Agents and Chemotherapy.

[25]  K. Kaye,et al.  Rifampin for therapy of experimental pneumococcal meningitis in rabbits , 1994, Antimicrobial Agents and Chemotherapy.

[26]  F. Sörgel,et al.  Lipophilicity at pH 7.4 and molecular size govern the entry of the free serum fraction of drugs into the cerebrospinal fluid in humans with uninflamed meninges , 1994, Journal of the Neurological Sciences.

[27]  K. Olsen,et al.  Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis , 1993, Antimicrobial Agents and Chemotherapy.

[28]  Sylvia,et al.  Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges , 1993, Antimicrobial Agents and Chemotherapy.

[29]  J. Cheesbrough,et al.  The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid. , 1993, The Journal of infection.

[30]  J. Karlowsky,et al.  Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli , 1992, Antimicrobial Agents and Chemotherapy.

[31]  J. Ariza,et al.  Evaluation of vancomycin for therapy of adult pneumococcal meningitis , 1991, Antimicrobial Agents and Chemotherapy.

[32]  M. Täuber,et al.  Use of ampicillin-sulbactam for treatment of experimental meningitis caused by a beta-lactamase-producing strain of Escherichia coli K-1 , 1991, Antimicrobial Agents and Chemotherapy.

[33]  O. Ramilo,et al.  Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis , 1991, Antimicrobial Agents and Chemotherapy.

[34]  G. Doern,et al.  Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States , 1990, Antimicrobial Agents and Chemotherapy.

[35]  M. Sachdeva,et al.  Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli , 1990, Antimicrobial Agents and Chemotherapy.

[36]  W. Scheld,et al.  Drug delivery to the central nervous system: general principles and relevance to therapy for infections of the central nervous system. , 1989, Reviews of infectious diseases.

[37]  W. Scheld.  Quinolone therapy for infections of the central nervous system. , 1989, Reviews of infectious diseases.

[38]  G. Overturf,et al.  Penetration of newer cephalosporins into cerebrospinal fluid. , 1989, Reviews of infectious diseases.

[39]  L. Hagberg,et al.  Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis , 1989, Antimicrobial Agents and Chemotherapy.

[40]  B. Régnier,et al.  Diffusion of ofloxacin into cerebrospinal fluid of patients with purulent meningitis or ventriculitis , 1989, Antimicrobial Agents and Chemotherapy.

[41]  G. Woodnutt,et al.  Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis , 1989, Antimicrobial Agents and Chemotherapy.

[42]  S. Kunz,et al.  Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits , 1989, Antimicrobial Agents and Chemotherapy.

[43]  S. Spector,et al.  Treatment of bacterial meningitis with once daily ceftriaxone therapy. , 1988, The Journal of antimicrobial chemotherapy.

[44]  G. Foulds,et al.  Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis , 1987, Antimicrobial Agents and Chemotherapy.

[45]  K. Olsen,et al.  Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis , 1987, Antimicrobial Agents and Chemotherapy.

[46]  R. Spector.  Ceftriaxone transport through the blood-brain barrier. , 1987, The Journal of infectious diseases.

[47]  W. Scheld,et al.  Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus. , 1987, The Journal of antimicrobial chemotherapy.

[48]  M. Sande,et al.  Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits. , 1986, The Journal of antimicrobial chemotherapy.

[49]  D. Forthal,et al.  Treatment of bacterial meningitis with ceftazidime. , 1986, Pediatric infectious disease.

[50]  A. Tomasz,et al.  Evaluation of the bactericidal activity of beta-lactam antibiotics on slowly growing bacteria cultured in the chemostat , 1986, Antimicrobial Agents and Chemotherapy.

[51]  P. Gutin,et al.  Vancomycin penetration of a brain abscess: case report and review of the literature. , 1986, Neurosurgery.

[52]  G. Kearns,et al.  Cerebrospinal fluid penetration of imipenem and cilastatin (primaxin) in children with central nervous system infections , 1986, Antimicrobial Agents and Chemotherapy.

[53]  D. Vittecoq,et al.  Penetration of aztreonam into cerebrospinal fluid of patients with bacterial meningitis , 1986, Antimicrobial Agents and Chemotherapy.

[54]  G. Kearns,et al.  Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis , 1985, Antimicrobial Agents and Chemotherapy.

[55]  M. Sande,et al.  Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis , 1985, Antimicrobial Agents and Chemotherapy.

[56]  A. Dajani,et al.  Cefotaxime diffusion into cerebrospinal fluid of children with meningitis , 1985, Antimicrobial Agents and Chemotherapy.

[57]  R. Greenman,et al.  Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation. , 1985, The Journal of antimicrobial chemotherapy.

[58]  M. Sande,et al.  New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits , 1985, Antimicrobial Agents and Chemotherapy.

[59]  A. Berry,et al.  Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges , 1984, Antimicrobial Agents and Chemotherapy.

[60]  J. Lefrock,et al.  Diffusion of ceftriaxone into the cerebrospinal fluid of adults. , 1984, The Journal of antimicrobial chemotherapy.

[61]  B. Régnier,et al.  Penetration of pefloxacin into cerebrospinal fluid of patients with meningitis , 1984, Antimicrobial Agents and Chemotherapy.

[62]  I. Fong,et al.  Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation , 1984, Antimicrobial Agents and Chemotherapy.

[63]  M. Sande,et al.  The postantibiotic effect in the treatment of experimental meningitis caused by Streptococcus pneumoniae in rabbits. , 1984, The Journal of infectious diseases.

[64]  T. Drake,et al.  Antibacterial activity of beta-lactam antibiotics in experimental meningitis due to Streptococcus pneumoniae. , 1984, The Journal of infectious diseases.

[65]  S. Lolekha,et al.  Cefuroxime treatment of bacterial meningitis in infants and children , 1984, Antimicrobial Agents and Chemotherapy.

[66]  C. Shikuma,et al.  Treatment of bacterial meningitis with ceftizoxime , 1984, Antimicrobial Agents and Chemotherapy.

[67]  B. Congeni.  Comparison of ceftriaxone and traditional therapy of bacterial meningitis , 1984, Antimicrobial Agents and Chemotherapy.

[68]  J. Ernst,et al.  Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis , 1983, Antimicrobial Agents and Chemotherapy.

[69]  R. W. Steele,et al.  Comparison of ceftriaxone with standard therapy for bacterial meningitis. , 1983, The Journal of pediatrics.

[70]  D. Vittecoq,et al.  Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis , 1983, Antimicrobial Agents and Chemotherapy.

[71]  G. Overturf,et al.  Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis , 1983, Antimicrobial Agents and Chemotherapy.

[72]  E. Wang,et al.  Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole. , 1983, The Journal of antimicrobial chemotherapy.

[73]  M. Sande,et al.  Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits. , 1983, The Journal of clinical investigation.

[74]  R. W. Steele,et al.  Pharmacokinetics of Ceftriaxone in Pediatric Patients With Meningitis , 1983, Antimicrobial Agents and Chemotherapy.

[75]  W. Scheld,et al.  Effect of methylprednisolone on entry of ampicillin and gentamicin into cerebrospinal fluid in experimental pneumococcal and Escherichia coli meningitis , 1983, Antimicrobial Agents and Chemotherapy.

[76]  A. Dajani,et al.  Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis , 1983, Antimicrobial Agents and Chemotherapy.

[77]  G. Mccracken,et al.  Pharmacokinetics of cefuroxime in infants and children with bacterial meningitis , 1982, Antimicrobial Agents and Chemotherapy.

[78]  M. Sande,et al.  Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis , 1982, Antimicrobial Agents and Chemotherapy.

[79]  S. Shelton,et al.  Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis , 1982, Antimicrobial Agents and Chemotherapy.

[80]  W. Scheld,et al.  Synergy Between Ampicillin and Gentamicin in Experimental Meningitis Due to Group B Streptococci , 1982 .

[81]  R. Yogev,et al.  Intraventricular levels of amikacin after intravenous administration , 1981, Antimicrobial Agents and Chemotherapy.

[82]  C. Papadatos,et al.  Clinical Pharmacology of Cefotaxime in Pediatric Patients , 1981, Antimicrobial Agents and Chemotherapy.

[83]  R. Greenman,et al.  Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid , 1981, Antimicrobial Agents and Chemotherapy.

[84]  S. Shulman,et al.  380 PENETRANCE OF NAFCILLIN INTO HUMAN VENTRICULAR FLUID: CORRELATION WITH VENTRICULAR PLEOCYTOSIS AND GLUCOSE LEVELS , 1981, Pediatric Research.

[85]  L. Strausbaugh,et al.  Effect of meningitis and probenecid on the penetration of vancomycin into cerebrospinal fluid in rabbits , 1980, Antimicrobial Agents and Chemotherapy.

[86]  G. Humbert,et al.  Cefoxitin concentrations in the cerebrospinal fluids of patients with meningitis , 1980, Antimicrobial Agents and Chemotherapy.

[87]  C. D. de Godoy,et al.  Cefoxitin penetration into cerebrospinal fluid in patients with purulent meningitis , 1980, Antimicrobial Agents and Chemotherapy.

[88]  G. Mccracken,et al.  Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis , 1980, Antimicrobial Agents and Chemotherapy.

[89]  C. Müller,et al.  The penetration of cefuroxime into the cerebrospinal fluid through inflamed and non-inflamed meninges. , 1980, The Journal of antimicrobial chemotherapy.

[90]  B. Belohradsky,et al.  INTRAVENOUS CEFOTAXIME IN CHILDREN WITH BACTERIAL MENINGITIS , 1980, The Lancet.

[91]  M. Sande,et al.  Response to therapy in an experimental rabbit model of meningitis due to Listeria monocytogenes. , 1979, The Journal of infectious diseases.

[92]  M. Sande,et al.  Mecillinam-Ampicillin Synergism in Experimental Enterobacteriaceae Meningitis , 1979, Antimicrobial Agents and Chemotherapy.

[93]  J. Rahal,et al.  Bactericidal and Bacteriostatic Action of Chloramphenicol Against Meningeal Pathogens , 1979, Antimicrobial Agents and Chemotherapy.

[94]  M. Sande,et al.  Comparison of Netilmicin with Gentamicin in the Therapy of Experimental Escherichia coli Meningitis , 1978, Antimicrobial Agents and Chemotherapy.

[95]  H. Robson,et al.  Cerebrospinal Fluid Penetration of Amikacin , 1978, Antimicrobial Agents and Chemotherapy.

[96]  M. Sande,et al.  Evaluation of cefamandole therapy of patients with bacterial meningitis. , 1978, The Journal of infectious diseases.

[97]  R. H. Parker,et al.  Nafcillin concentration in cerebrospinal fluid during treatment of staphylococcal infections. , 1977, Annals of internal medicine.

[98]  J. Nelson,et al.  A pharmacologic evaluation of penicillin in children with purulent meningitis. , 1977, The New England journal of medicine.

[99]  L. Baraff,et al.  Penetration of Cefamandole into Spinal Fluid , 1977, Antimicrobial Agents and Chemotherapy.

[100]  R. H. Parker,et al.  Nafcillin Entry into Human Cerebrospinal Fluid , 1977, Antimicrobial Agents and Chemotherapy.

[101]  L. Jokipii,et al.  Penetration of the blood brain barrier by metronidazole and tinidazole. , 1977, The Journal of antimicrobial chemotherapy.

[102]  J. Thys,et al.  Pharmacological Study of Cefazolin During Intermittent and Continuous Infusion: a Crossover Investigation in Humans , 1976, Antimicrobial Agents and Chemotherapy.

[103]  S. R. Snodgrass,et al.  The effect of uremia on penicillin flux between blood and cerebrospinal fluid. , 1976, The Journal of laboratory and clinical medicine.

[104]  Z. A. McGee,et al.  Aminoglycoside therapy of gram-negative bacillary meningitis. , 1975, The New England journal of medicine.

[105]  H. Wilson,et al.  Ampicillin in Haemophilus influenzae meningitis. Clinicopharmacologic evaluation of intramuscular vs intravenous administration. , 1975, American journal of diseases of children.

[106]  M. Sande,et al.  Effect of Probenecid on Cerebrospinal Fluid Concentrations of Penicillin and Cephalosporin Derivatives , 1974, Antimicrobial Agents and Chemotherapy.

[107]  A. Lorenzo,et al.  Inhibition of penicillin transport from the cerebrospinal fluid after intracisternal inoculation of bacteria. , 1974, The Journal of clinical investigation.

[108]  D. Rall,et al.  Evidence of active transport of benzyl-14C-penicillin from cerebrospinal fluid to blood. , 1969, Journal of pharmaceutical sciences.

[109]  M. Karnovsky,et al.  FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE , 1967, The Journal of cell biology.

[110]  R. Fishman.  Blood-brain and CSF barriers to penicillin and related organic acids. , 1966, Archives of neurology.

[111]  C. Kunin.  EFFECT OF SERUM BINDING ON THE DISTRIBUTION OF PENICILLINS IN THE RABBIT. , 1965, The Journal of laboratory and clinical medicine.

[112]  R. Koch,et al.  Treatment of acute purulent meningitis with tetracycline. , 1957, The Journal of pediatrics.

[113]  W. Craig.  Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[114]  J. Bennett,et al.  Mandell, Douglas and Bennett's principles and practice of infectious diseases. Volumes 1 and 2. Fourth edition. , 1995 .

[115]  M. Täuber,et al.  Pharmacodynamics of antibiotics in the therapy of meningitis: infection model observations. , 1993, The Journal of antimicrobial chemotherapy.

[116]  W. Craig,et al.  Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man. , 1993, The Journal of antimicrobial chemotherapy.

[117]  A. Péchinot,et al.  Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis. , 1992, The Journal of antimicrobial chemotherapy.

[118]  W. Craig,et al.  Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[119]  G. Overturf,et al.  Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime. , 1982, The Journal of antimicrobial chemotherapy.

[120]  L. Jokipii,et al.  Metronidazole, tinidazole, ornidazole and anaerobic infections of the middle ear, maxillary sinus and central nervous system. , 1981, Scandinavian journal of infectious diseases. Supplementum.

[121]  M. Sande,et al.  Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. , 1981, Reviews of infectious diseases.

[122]  C. Müller,et al.  Concentration of cefuroxime in cerebrospinal fluid in patients with bacterial meningitis. , 1981, Scandinavian journal of infectious diseases.

[123]  G. Hodges,et al.  Penetration of cefoxitin into human cerebrospinal fluid: comparison with cefamandole, ampicillin, and penicillin. , 1979, Reviews of infectious diseases.

[124]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[125]  G. M. Findlay.  Recent advances in chemotherapy , 1939 .